Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
KAMADA LTD (KMDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Provides Corporate Update on its Israel Operations"
08/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance",
"COMPANY'S PRESENTATION - AUGUST 2023",
"KAMADA LTD'S CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 (UNAUDITED)"
08/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023"
07/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "CURRENT REPORT",
" ",
" "
07/12/2023 6-K Quarterly results
05/24/2023 SC 13D/A DAVIDI ISHAY reports a 21.1% stake in Kamada Ltd.
05/24/2023 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
05/24/2023 6-K Quarterly results
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance",
"Company's Presentation – May 2023",
"Kamada Ltd's Consolidated Financial Statements as of March 31, 2023 (Unaudited)"
05/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Announces Chief Financial Officer Chaime Orlev to Remain in Role and Appointment of Nir Livneh as Vice President, General Counsel and Corporate Secretary"
05/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds"
05/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023"
05/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland"
05/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company’ s Facility in Israel"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Issues 2023 CEO Letter to Shareholders",
"Kamada 2022 Results Presentation"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Files Annual Report for the Year Ended December 31, 2022"
03/15/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, and Provides 2023 Guidance Representing Significant Profitability Growth"
03/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 15, 2023"
01/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’ s Facility in Israel"
12/22/2022 6-K Quarterly results
12/19/2022 6-K Quarterly results
11/22/2022 6-K Quarterly results
11/17/2022 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/16/2022 6-K Quarterly results
11/08/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "CURRENT REPORT",
" ",
" "
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "REPORT OF FOREIGN PRIVATE ISSUER",
"Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT"
10/26/2022 6-K Quarterly results
10/19/2022 6-K Quarterly results
08/17/2022 6-K Quarterly results
08/10/2022 6-K Quarterly results
07/15/2022 6-K Quarterly results
07/06/2022 6-K Quarterly results
06/28/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/15/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy